Forward-looking statements
Certain statements on this website are forward-looking and involve risks and uncertainties. Actual results may differ materially.
Last updated: Q2 2025
Cautionary note
This website contains forward-looking statements regarding Regenerative Medical Technology Group Inc. (“RMTG”) and its operating businesses. These statements reflect current expectations and are based on assumptions that are subject to risks and uncertainties.
Risks and uncertainties
Forward-looking statements are subject to factors that could cause actual results to differ materially, including market conditions, regulatory developments, competition, execution of the company’s growth strategy, and other risks described in the company’s filings.
Reliance on SEC filings
Investors should rely on the company’s official filings with the U.S. Securities and Exchange Commission (EDGAR, CIK 1760026) for authoritative and material information. Any stock information shown on this site is delayed and provided for reference only.
No obligation to update
RMTG undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.